Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry.

AIMS Stroke patients with atrial fibrillation (AF) have a poorer neurological outcome than stroke patients without AF. Whether stroke patients with AF also have a higher rate of medical complications is unknown. The aim of the study was to compare the in-hospital course of acute stroke patients with and without AF. METHODS AND RESULTS The Austrian Stroke registry was a prospective multi-centre study involving 57 medical departments documenting the hospital course of consecutive stroke patients from June 1999 to October 2000. AF was diagnosed in 304 (31%) of 992 patients. Patients with AF were older (79 versus 75 years, p < 0.0004) than no-AF patients. There were more cases of pneumonia (23% versus 9%, p < 0.0004), pulmonary oedema (12% versus 6%, p < 0.0004) and symptomatic intracerebral haemorrhage (8% versus 2%, p < 0.0004) in AF compared to no-AF. In-hospital mortality was higher in AF (25% versus 14%, p < 0.0004), and neurological outcome was poorer (65 versus 90 Barthel index, p < 0.0004). On multivariable logistic regression analysis, however, AF was no predictor for mortality, but a Barthel index of zero (odds ratio 5.30, 95% CI 3.10-9.08, p < 0.0001), a National Institutes of Health Stroke Scale > 21 or comatose (odds ratio 3.13, 95% CI 2.26-4.32, p < 0.0001), age > 75 years (odds ratio 3.15, 95% CI 1.85-5.37, p < 0.0001), heart rate > 100 min(-1) (odds ratio 2.15, 95% CI 1.26-3.66, p = 0.0049), obstructive pulmonary disease (odds ratio 2.58, 95% CI 1.03-6.48, p = 0.0442) and creatinine > 125 micromol/l (odds ratio 1.84, 95% CI 1.00-3.37, p = 0.0479). CONCLUSION Stroke in AF is associated with a poor prognosis, an increased rate of medical and neurological complications and a higher in-hospital mortality than in no-AF.

[1]  W. Lalouschek,et al.  Current Strategies of Secondary Prevention After a Cerebrovascular Event: The Vienna Stroke Registry , 2001, Stroke.

[2]  P. Sandercock,et al.  Risk of Early Death and Recurrent Stroke and Effect of Heparin in 3169 Patients With Acute Ischemic Stroke and Atrial Fibrillation in the International Stroke Trial , 2001, Stroke.

[3]  J. Slattery,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1989, Stroke.

[4]  Eaft Study Group.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993, The Lancet.

[5]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[6]  R B D'Agostino,et al.  Stroke severity in atrial fibrillation. The Framingham Study. , 1996, Stroke.

[7]  Leandro Provinciali,et al.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .

[8]  J. Carlsson,et al.  Neurologische Ereignisse bei Patienten mit Vorhofflimmern: Outcome und Präventionspraxis , 2000, Zeitschrift für Kardiologie.

[9]  Caroline Leigh Watkins.  The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997 .

[10]  R. Kaiser,et al.  Insultbehandlung an Internen Abteilungen1 - Eine österreichische Multizenterstudie - , 2002 .

[11]  M. Vassallo,et al.  Strokes in the Elderly – Higher Acute and 3-Month Mortality – An Explanation , 1999, Cerebrovascular Diseases.

[12]  Yuchiao Chang,et al.  Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. , 2003, The New England journal of medicine.

[13]  Mahoney Fi,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 1965 .

[14]  D. Singer,et al.  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[15]  F. McAlister,et al.  Why do patients with atrial fibrillation not receive warfarin? , 2000, Archives of internal medicine.

[16]  Peter Sandercock,et al.  The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997, The Lancet.

[17]  C. Wolfe,et al.  Characteristics, Outcome, and Care of Stroke Associated With Atrial Fibrillation in Europe: Data From a Multicenter Multinational Hospital–Based Registry (The European Community Stroke Project) , 2001, Stroke.

[18]  R Kaiser,et al.  [Stroke management on general medical departments. A multicenter study in Austria]. , 2002, Deutsche medizinische Wochenschrift.

[19]  T. Olsen,et al.  Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. , 1996, Stroke.

[20]  R. Levine,et al.  Atrial Fibrillation Is Associated with Severe Acute Ischemic Stroke , 2003, Neuroepidemiology.

[21]  S. Kemp,et al.  Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals , 1997, Neurology.

[22]  J. Marler,et al.  Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.

[23]  Frank J. Hildner,et al.  ArticlesAntithrombotic Therapy in Atrial Fibrillation , 1989 .

[24]  D. Singer,et al.  Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. , 2000, Circulation.

[25]  J C Sharma,et al.  Cardiovascular disease and outcome of acute stroke: influence of pre‐existing cardiac failure , 2000, European journal of heart failure.

[26]  E. Roth,et al.  Incidence of and Risk Factors for Medical Complications During Stroke Rehabilitation , 2001, Stroke.